The emerging approach of the medication represents a exciting development in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment